These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30054)

  • 21. A new form of polypharmacy?
    Winstead DK
    Am J Psychiatry; 1979 Jun; 136(6):861-2. PubMed ID: 35990
    [No Abstract]   [Full Text] [Related]  

  • 22. Tardive dyskinesia.
    Gerlach J
    Dan Med Bull; 1979 Aug; 26(5):209-45. PubMed ID: 40756
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
    Höflich G; Burghof KW; Kasper S; Möller HJ
    Nervenarzt; 1994 Mar; 65(3):202-5. PubMed ID: 7909917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology of Parkinson disease].
    Domínguez Carmona M
    An R Acad Nac Med (Madr); 1989; 106(2):175-220. PubMed ID: 2574955
    [No Abstract]   [Full Text] [Related]  

  • 25. Reducing unnecessary antiparkinson medication in antinsychotic therapy.
    Raleigh FR
    J Am Pharm Assoc; 1977 Feb; 17(2):101-2, 106. PubMed ID: 14986
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of new pharmacological approaches in Parkinson's disease.
    Carlsson A
    Adv Neurol; 1987; 45():513-8. PubMed ID: 3493631
    [No Abstract]   [Full Text] [Related]  

  • 27. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.
    Trosch RM; Friedman JH; Lannon MC; Pahwa R; Smith D; Seeberger LC; O'Brien CF; LeWitt PA; Koller WC
    Mov Disord; 1998 May; 13(3):377-82. PubMed ID: 9613725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE; Stewart RB
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 30. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of parkinsonism].
    Hennicke H
    Psychiatr Neurol Med Psychol Beih; 1966; 4-5():115-20. PubMed ID: 5006301
    [No Abstract]   [Full Text] [Related]  

  • 32. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 34. Metoprolol in the treatment of neuroleptic-induced tremor: case report.
    Chaturvedi SK
    J Clin Psychiatry; 1987 Sep; 48(9):378. PubMed ID: 2887551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I
    Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics].
    Arnone A; Parodi A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1126-42. PubMed ID: 5143724
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychosis in Parkinson's disease: how should we treat it?
    Shotbolt P; Samuel M; Anthony D
    Expert Rev Neurother; 2006 Sep; 6(9):1243-6. PubMed ID: 17009911
    [No Abstract]   [Full Text] [Related]  

  • 38. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A; Landry P; Deschamps R; Lessard M
    Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of psychotic symptoms associated with the disease and its treatments.
    Monias A; Samuels SC
    Geriatrics; 2001 Nov; 56(11):56-7. PubMed ID: 11710816
    [No Abstract]   [Full Text] [Related]  

  • 40. Parkinson disease.
    Friedman JH
    N Y State J Med; 1987 Mar; 87(3):139-40. PubMed ID: 3472108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.